徐登月

个人简介：

徐登月，医学博士、中级医师

主要从事心血管系统疾病的临床诊疗和基础研究。 

 研究方向：

1、心血管疾病的基础和临床研究

2、cpFP探针在心血管系统中的应用

学术兼职：

无

科研情况：

参与国家自然科学基金课题1项，中央引导地方科技发展基金1项。

教育经历：

2020.9-2023.6 中国医科大学-临床医学-博士

2013.7-2015.7 大连医科大学-临床医学-硕士

2008.9-2013.7 大连医科大学-临床医学-学士

工作经历：

2015.9-2020.8 大连市中心医院-医师

论文成果：

[1]     Dengyue Xu, Chennian Xu, Xiaodong Xue, Yinli Xu, Jikai Zhao, Tao Huang, Zhishang Wang, Qiusheng Zhao, Zijun Zhou, Yuting Huang, Liming Yu, Huishan Wang. Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism. Front Cardiovasc Med. 2022, 14(9):968014. doi: 10.3389/fcvm.2022.968014.

[2]     Dengyue Xu, Hengxia Qiu, Ze Li, Peishi Yan, He Xu, Yu Gu, Hinlong Lin. The Influence of Factors such as Anxiety on the White Coat Effect during the Treatment of Patients with Hypertension. Rev Cardiovasc Med. 2022, 23(11), 359. doi：10.31083/j.rcm2311359.

[3]     徐登月,于立明,王辉山.氧化应激作用于房颤发病机制中的研究现状[J].中国临床药理学杂志,2023,39(04):583-587. doi: 10.13699/j.cnki.1001-6821.

[4]     He Jian, Xu Dengyue, Wang Lu, Yu Xiaohong. Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro. Front Pharmacol. 2023 Jan 4;13:1079251. doi: 10.3389/fphar.2022.1079251.

[5]     Zhao Jikai, Yu Liming, Xue Xiaodong, Xu Yinli, Huang Tao, Xu Dengyue, Wang Zhishang, Luo Linyu, Wang Huishan. Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress. Redox Biol. 2023 Feb;59:102594. doi: 10.1016/j.redox.2022.102594.

[6]     Chen Yuqiong, Li Su, Zhang Yan, Wang Mengshen, Li Xinyan, Liu Shuang, Xu Dengyue, Bao Yandong, Jia Pengyu, Wu Nan, Lu Yao, Jia Dalin. The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. Redox Biol. 2021 May;41:101910. doi: 10.1016/j.redox.2021.101910.

专利：

无